Earnings Call · Q1 FY2024·2024-05-07

Q1 24EPS 0.00%·Rev n/aQ4 23EPS +2.30%·Rev n/aQ3 23EPS -7.69%·Rev n/aQ2 23EPS +2.63%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Head of Investor Relations

Frank Lee — Chief Executive Officer

Unknown — Chief Executive Officer

Charles Reinhart — Chief Financial Officer

Turning to guidance. Today, we reiterate our full year guidance for 2024 as follows — Chief Financial Officer

+11.8%1d on move date+11.8% vs SPY3d+11.0%5d+16.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access